Form 4 for PMVP PMV Pharmaceuticals, Inc.
Accepted 2024-01-22 00:00:00 ET · period of report 2024-01-18 · accession 0001209191-24-001993 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-22 | 2024-01-18 | PMVP | Mack David Henry | Pres, CEO, Dir | A - Grant | $0.00 | +163.9K | 442.5K | +59% | $0 |
| D | 2024-01-22 | 2024-01-18 | PMVP | Mack David Henry | Pres, CEO, Dir | A - Grant | $0.00 | +519.9K | 519.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-18 | A | A | 163,890 | $0.00 | 442,460 | D | — | — | (F1) The reported shares are represented by restricted stock units, or RSUs, all of which vest on June 30, 2025. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2024-01-18 | A | A | 519,915 | $0.00 | 519,915 | D | $1.80 · — to 2034-01-18 | 519,915 Common Stock | (F4) Shares subject to the option vest in 48 equal monthly installments beginning on February 18, 2024. |